ArticleFrontiers in oncology2021

Immune-Related Multiple-Organs Injuries Following ICI Treatment With Tislelizumab in an Advanced Non-Small Cell Lung Cancer Patient: A Case Report.

Chao Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.